Induction of apoptosis in MDR1 expressing cells by daunorubicin with combinations of suboptimal concentrations of P-glycoprotein modulators

被引:12
作者
Aszalos, A
Ladányi, A
Bocsi, J
Szende, B
机构
[1] Natl Inst Oncol, Dept Tumor Progress, H-1122 Budapest, Hungary
[2] NCI, NIH, Bethesda, MD 20892 USA
[3] Semmelweis Univ, Inst Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary
关键词
multidrug resistance; Pgp inhibitors; daunorubicin; apoptosis;
D O I
10.1016/S0304-3835(01)00488-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The application of most agents with the capacity to reverse multidrug resistance (MDR) via modulation of the multidrug transporter P-glycoprotein (Pgp) was shown to be associated with toxic side-effects. For this reason, we have investigated the effect of combinations of suboptimal concentrations of Pgp blockers on the induction of apoptosis and growth arrest in daunorubicin (D) treated, MDRI gene transfected cells. We used verapamil, PSC833 and Cremophor EL as Pgp modulators, which affect the function of Pgp by different mechanisms. Treatment of NIH3T3/MDR1 cells with combinations of suboptimal concentrations of Pgp modulators in the presence of D caused apoptosis and G(2) arrest to the same extent as optimal concentrations of singly used blockers. We conclude that combinations of suboptimal concentrations of Pgp modulators may cause effective sensitization of resistant tumor cells, and at the same time, may avoid the frequently observed toxic effects experienced in clinical trials with a single modifier applied at the optimal dose. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:157 / 162
页数:6
相关论文
共 50 条
[1]   Relationship between expression level of P-glycoprotein and daunorubicin transport in LLC-PK1 cells transfected with human MDR1 gene [J].
Tanaka, K ;
Hirai, M ;
Tanigawara, Y ;
Ueda, K ;
Takano, M ;
Hori, R ;
Inui, K .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (05) :741-746
[2]   Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells [J].
Nadali, Fatemeh ;
Pourfathollah, Ali-Akbar ;
Alimoghaddam, Kamran ;
Nikougoftar, Mahin ;
Rostami, Shahrbano ;
Dizaji, Abdolkhlegh ;
Azizi, Ebrahim ;
Zomorodipour, Alireza ;
Ghavamzadeh, Ardeshir .
HEMATOLOGY, 2007, 12 (05) :393-401
[3]   EXPRESSION OF THE MDR1 P-GLYCOPROTEIN GENE - A MECHANISM OF ESCAPE FROM GLUCOCORTICOID-INDUCED APOPTOSIS [J].
GRUOL, DJ ;
BOURGEOIS, S .
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1994, 72 (11-12) :561-571
[4]   EXPRESSION OF MDR1/P-GLYCOPROTEIN AND P110 IN NEUROBLASTOMA [J].
RAMANI, P ;
DEWCHAND, H .
JOURNAL OF PATHOLOGY, 1995, 175 (01) :13-22
[5]   Determining MDR1/P-glycoprotein expression in breast cancer [J].
Faneyte, IF ;
Kristel, PMP ;
van de Vijver, MJ .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (01) :114-122
[6]   The role of P-glycoprotein (MDR1) polymorphisms and mutations in colorectal cancer [J].
Potocnik, U ;
Glavac, MR ;
Golouh, R ;
Glavac, D .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2001, 442 (06) :R182-R183
[7]   Expression of the MDR1 gene product P-glycoprotein in childhood neuroblastoma [J].
Dhooge, CRM ;
DeMoerloose, BMJ ;
Benoit, YCM ;
VanRoy, N ;
Philippe, J ;
Laureys, GGM .
CANCER, 1997, 80 (07) :1250-1257
[8]   The role of P-glycoprotein (MDR1) polymorphisms and mutations in colorectal cancer [J].
Uroš Potočnik ;
Metka Ravnik Glavač ;
Rastko Golouh ;
Damjan Glavač .
Pflügers Archiv, 2001, 442 :r182-r183
[9]   Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine [J].
Riffkin, CD ;
Chung, R ;
Wall, DM ;
Zalcberg, JR ;
Cowman, AF ;
Foley, M ;
Tilley, L .
BIOCHEMICAL PHARMACOLOGY, 1996, 52 (10) :1545-1552
[10]   Mdr1 transfection causes enhanced apoptosis by paclitaxel:: An effect independent of drug efflux function of p-glycoprotein [J].
Li, D ;
Au, JLS .
PHARMACEUTICAL RESEARCH, 2001, 18 (07) :907-913